Schedule 13D ownership disclosure

NEUPHORIA THERAPEUTICS INC

Common Stock · CUSIP: 64136E102

Event date: 2025-01-24

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Apeiron Investment Group Ltd.Reported CIK 0001845711

    Shares: 72,618 · Class: 4.5%

  • Apeiron Presight Capital Fund II, L.P.Reported CIK 0001840676

    Shares: 0 · Class: 0%

  • Presight Capital Management I, L.L.C.

    Shares: 0 · Class: 0%

  • Fabian Hansen

    Shares: 0 · Class: 0%

  • Christian AngermayerReported CIK 0001845872

    Shares: 72,618 · Class: 4.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-009848
Form type
SCHEDULE 13D/A
Filer
Apeiron Investment Group Ltd.
CIK
CIK 1845711
Filed
Jan 28, 2025
Reporting period
Jan 24, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub